Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IgA nephropathy: 30 years on

E Pettersson1

  • 1Department of Renal Medicine, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.

Journal of Internal Medicine
|January 4, 1998
PubMed
Summary
This summary is machine-generated.

Immunoglobulin A nephropathy (IgAN) is the most common glomerulonephritis worldwide, often presenting with hematuria. While initially thought benign, IgAN can progress to kidney failure, necessitating blood pressure management due to unclear causes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic pain conditions and risk of suicidal behavior: a 10-year longitudinal co-twin control study.

BMC medicine·2023
Same author

COMPARISON OF METAL ARTEFACTS FOR DIFFERENT DUAL ENERGY CT TECHNIQUES.

Radiation protection dosimetry·2021
Same author

Genetic influences on eight psychiatric disorders based on family data of 4 408 646 full and half-siblings, and genetic data of 333 748 cases and controls - CORRIGENDUM.

Psychological medicine·2018
Same author

Genetic influences on eight psychiatric disorders based on family data of 4 408 646 full and half-siblings, and genetic data of 333 748 cases and controls.

Psychological medicine·2018
Same author

Common psychiatric disorders share the same genetic origin: a multivariate sibling study of the Swedish population.

Molecular psychiatry·2015
Same author

Validation of phototesting for estimation of individual skin ultraviolet sensitivity based on a lengthwise attenuating ultraviolet B field.

Journal of medical engineering & technology·2014
Same journal

Expected survival is decreased in hereditary hemorrhagic telangiectasia: Results from a population-based registry study.

Journal of internal medicine·2026
Same journal

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Journal of internal medicine·2026
Same journal

Patients with hereditary hemorrhagic telangiectasia have significantly reduced overall survival-And likely by a greater magnitude than we realize.

Journal of internal medicine·2026
Same journal

Social jet lag is associated with incident cardiovascular disease independent of sleep duration and cardiac genetic risk.

Journal of internal medicine·2026
Same journal

Multicenter validation of a severity index model for predicting postoperative acute kidney injury.

Journal of internal medicine·2026
Same journal

The changing epidemiology of human type 2 diabetes-associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities.

Journal of internal medicine·2026
See all related articles

Area of Science:

  • Nephrology
  • Immunology
  • Internal Medicine

Background:

  • Immunoglobulin A nephropathy (IgAN) is the most prevalent primary glomerulonephritis globally.
  • Common symptoms include hematuria and proteinuria.
  • Historically viewed as benign, IgAN is now recognized as a progressive disease potentially leading to end-stage renal disease within decades.

Purpose of the Study:

  • To review the current understanding of IgA nephropathy.
  • To highlight the progressive nature and unclear etiology of IgAN.
  • To emphasize the current therapeutic cornerstone for IgAN management.

Main Methods:

  • Review of long-term follow-up studies on IgA nephropathy.
  • Analysis of clinical presentation and disease progression.

Related Experiment Videos

  • Examination of current etiological and pathogenetic hypotheses.

    • Main Results:

    • IgAN is the leading cause of primary glomerulonephritis worldwide.
    • Up to 50% of patients may develop end-stage renal failure.
    • The underlying cause involves a poorly understood immune response dysregulation.

    Conclusions:

    • IgA nephropathy is a significant progressive renal disease.
    • No specific treatment currently exists for IgAN.
    • Effective blood pressure control remains the primary therapeutic strategy.